MX2021000899A - Composiciones y metodos para determinar el pronostico de cancer de endometrio. - Google Patents

Composiciones y metodos para determinar el pronostico de cancer de endometrio.

Info

Publication number
MX2021000899A
MX2021000899A MX2021000899A MX2021000899A MX2021000899A MX 2021000899 A MX2021000899 A MX 2021000899A MX 2021000899 A MX2021000899 A MX 2021000899A MX 2021000899 A MX2021000899 A MX 2021000899A MX 2021000899 A MX2021000899 A MX 2021000899A
Authority
MX
Mexico
Prior art keywords
endometrial cancer
compositions
methods
determining
cancer prognosis
Prior art date
Application number
MX2021000899A
Other languages
English (en)
Inventor
Kevin J Arvai
Yongbao Wang
Daniel Jones
Original Assignee
Quest Diagnostics Invest Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest Diagnostics Invest Llc filed Critical Quest Diagnostics Invest Llc
Publication of MX2021000899A publication Critical patent/MX2021000899A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención proporciona métodos y composiciones para determinar el pronóstico en individuos con cáncer, en particular cáncer de endometrio. La presente invención también proporciona métodos para desarrollar y usar modelos predictivos que son útiles para determinar el pronóstico de cáncer de endometrio y otras enfermedades similares. La presente invención además proporciona métodos para determinar el estado de microsatélites usando secuenciación de nueva generación.
MX2021000899A 2015-02-06 2017-08-04 Composiciones y metodos para determinar el pronostico de cancer de endometrio. MX2021000899A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562113340P 2015-02-06 2015-02-06
US201562113990P 2015-02-09 2015-02-09

Publications (1)

Publication Number Publication Date
MX2021000899A true MX2021000899A (es) 2021-03-31

Family

ID=56564751

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017010122A MX2017010122A (es) 2015-02-06 2016-02-05 Composiciones y metodos para determinar el pronostico de cancer de endometrio.
MX2021000899A MX2021000899A (es) 2015-02-06 2017-08-04 Composiciones y metodos para determinar el pronostico de cancer de endometrio.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2017010122A MX2017010122A (es) 2015-02-06 2016-02-05 Composiciones y metodos para determinar el pronostico de cancer de endometrio.

Country Status (7)

Country Link
US (2) US20180094301A1 (es)
EP (2) EP3253891B1 (es)
CN (2) CN115094141A (es)
BR (1) BR112017016752A2 (es)
CA (1) CA2975737A1 (es)
MX (2) MX2017010122A (es)
WO (1) WO2016127067A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201614474D0 (en) * 2016-08-24 2016-10-05 Univ Of Newcastle Upon Tyne The Methods of identifying microsatellite instability
EP3612643A4 (en) * 2017-04-21 2020-12-23 The University of British Columbia STRATIFICATION AND FORECAST OF CANCER
WO2019074963A1 (en) 2017-10-09 2019-04-18 Strata Oncology, Inc. CHARACTERIZATION OF THE INSTABILITY OF MICROSATELLITES
CN108814592A (zh) * 2018-04-24 2018-11-16 哈尔滨工业大学 基于小波能量判定癫痫发作前脑电信号的方法及系统
EP3935193A1 (en) * 2019-03-06 2022-01-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Method to diagnose a cmmrd
CN112037859B (zh) * 2020-09-02 2023-12-19 迈杰转化医学研究(苏州)有限公司 一种微卫星不稳定性的分析方法和分析装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO573697A0 (en) * 1997-03-20 1997-04-10 Prince Henry's Institute Of Medical Research Diagnosis of endometrial cancer
EP1522594A3 (en) * 2003-10-06 2005-06-22 Bayer HealthCare AG Methods and kits for investigating cancer
US20100196509A1 (en) * 2005-02-28 2010-08-05 Jonathan Braun Methods for Diagnosis and Treatment of Endometrial Cancer
EP2155905A1 (en) * 2007-05-31 2010-02-24 Dako Denmark A/S Methods for utilizing esr copy number changes in breast cancer treatments and prognoses
JP2013507904A (ja) * 2009-07-17 2013-03-07 ザ・トランスレーショナル・ジェノミクス・リサーチ・インスティチュート 癌のリスク評価に使用する方法及びキット
WO2013056178A2 (en) * 2011-10-14 2013-04-18 Foundation Medicine, Inc. Novel estrogen receptor mutations and uses thereof
CN103547683A (zh) * 2012-03-22 2014-01-29 耶鲁大学 Kras突变和肿瘤生物学

Also Published As

Publication number Publication date
US20230193358A1 (en) 2023-06-22
CN107532208B (zh) 2022-07-05
EP3253891A1 (en) 2017-12-13
EP3819389B1 (en) 2024-03-20
EP3253891B1 (en) 2020-11-11
EP3819389A1 (en) 2021-05-12
WO2016127067A1 (en) 2016-08-11
EP3253891A4 (en) 2018-09-19
CN107532208A (zh) 2018-01-02
MX2017010122A (es) 2018-06-06
CN115094141A (zh) 2022-09-23
CA2975737A1 (en) 2016-08-11
BR112017016752A2 (pt) 2018-04-10
US20180094301A1 (en) 2018-04-05

Similar Documents

Publication Publication Date Title
MX2021000899A (es) Composiciones y metodos para determinar el pronostico de cancer de endometrio.
PH12018502225A1 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
MX2020009649A (es) Anticuerpos monoclonales contra bcma.
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
MX2017003478A (es) Anticuerpos anti-fgfr2/3 y metodos para su uso.
MX2022010623A (es) Terapias de combinacion que comprenden un receptor quimerico de antigeno cd19 para el cancer.
MX2019007021A (es) Anticuerpos il-11ra.
BR112016008541A2 (pt) composições úteis para tratar distúrbios relacionados a kit
MX2019015159A (es) Composiciones, metodos y usos para asistir en el diagnostico, pronostico y tratamiento de la fibrosis pulmonar idiopatica.
MX340453B (es) Biomarcadores para cancer de pulmon.
MX2022001085A (es) Anticuerpos anti-c1s humanizados y metodos para usarlos.
MX2016010237A (es) Metodos de tratamiento de enfermedad de alzheimer.
GB2540702A (en) Nucleic acid processing of a nucleic acid fragment with a triazole linkage
MY183189A (en) Non-human animals having a humanized a proliferation-inducing ligand gene
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX2023012628A (es) Metodos y composiciones para deteccion y diagnostico de enfermedades renales y enfermedades periodontales.
MX2018000395A (es) Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso.
MX2016015163A (es) Biomarcadores mit y metodos para su uso.
BR112016021066A2 (pt) anticorpos humanizados com estabilidade aumentada
PH12017502277A1 (en) Multi-specific binding proteins
TN2018000197A1 (en) Compositions and methods for assessing the risk of cancer occurrence
MX2017013729A (es) Deteccion especifica de isoformas de clusterina.
MX2018004005A (es) Ensayo de potencia celular.
CY1125282T1 (el) Υδροξυλιωση στη θεση 21 των στεροειδων